In pancreatic cancer, gene mutations in the KEAP1/NRF2 pathway are rare; however, NRF2 expression levels are high in over 93% of pancreatic adenocarcinomas [14]. The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.